Develops EpiFinder, a high-throughput epigenetic screening platform for drug discovery and multi-omics research.
| Date | Round | Amount |
|---|---|---|
| Jun 2025 | Funding round Epigenica raised $2.2M led by Voima Ventures to expand the product portfolio of the EpiFinder platform and enter the US market. | $2.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.